The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability
Open accessAbstract
Little is known about the genetics of nonsyndromic intellectual disability (NSID). We hypothesized that de novo mutations (DNMs) in synaptic genes explain an important fraction of sporadic NSID cases. In order to investigate this possibility, we sequenced 197 genes encoding glutamate receptors and a large subset of their known interacting proteins in 95 sporadic cases of NSID. We found 11 DNMs, including ten potentially deleterious mutations (three nonsense, two splicing, one frameshift, four missense) and one neutral mutation (silent) in eight different genes. Calculation of point-substitution DNM rates per functional and neutral site showed significant excess of functional DNMs compared to neutral ones. De novo truncating and/or splicing mutations in SYNGAP1, STXBP1, and SHANK3 were found in six patients and are likely to be pathogenic. De novo missense mutations were found in KIF1A, GRIN1, CACNG2, and EPB41L1. Functional studies showed that all these missense mutations affect protein function in cell culture systems, suggesting that they may be pathogenic. Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup). This mutation also affects protein function, consistent with structural predictions. None of these mutations or any other DNMs were identified in these genes in 285 healthy controls. This study highlights the importance of the glutamate receptor complexes in NSID and further supports the role of DNMs in this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Δex4-9 (Bozdagi et al., 2010) and Δex4-7 mutations in mouse (Peca et al., 2011) are closest to patients with intragenic exon 1-9 deletion and splice mutation of intron 5 in SHANK3 (Bonaglia et al., 2011; Hamdan et al., 2011)”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Hamdan et al., 2011
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. F. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 7,031
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,601
Kinesin superfamily motor proteins and intracellular transport
Hirokawa, N., Noda, Y., Tanaka, Y., & Niwa, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2774 · Cited by 1,859 · cited 2×
“cargo-binding domains.(30,31) Thr(99) lies in the highly conserved p loop consensus ATP-binding site of the KIF1A motor domain (GQT(99)XXGKT/S) (Figure S2).”
BackgroundDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Protein structure homology modeling using SWISS-MODEL workspace
Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J. N. D., & Schwede, T. F. (2008) · Nature Protocols · doi:10.1038/nprot.2008.197 · Cited by 1,233
Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms
Chen, L., Chetkovich, D. M., Petralia, R. S., Sweeney, N. T., Kawasaki, Y., Wenthold, R. J., Bredt, D. S., & Nicoll, R. A. (2000) · Nature · doi:10.1038/35050030 · Cited by 1,111
Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing
Roach, J. C., Glusman, G., Smit, A. F. A., Huff, C. D., Hubley, R., Shannon, P. T., Rowen, L., Pant, K. P., Goodman, N., Bamshad, M., et al. (2010) · Science · doi:10.1126/science.1186802 · Cited by 1,084
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Prediction of deleterious human alleles
Sunyaev, S. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,053
Cited by
Sorted by citations
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247
Deep sequencing reveals 50 novel genes for recessive cognitive disorders
Najmabadi, H., Hu, H., Garshasbi, M., Zemojtel, T., Abedini, S. S., Chen, W., Hosseini, M., Behjati, F., Haas, S., Jamali, P., et al. (2011) · Nature · doi:10.1038/nature10423 · Cited by 965
De novo mutations in human genetic disease
Veltman, J. A., & Brunner, H. G. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3241 · Cited by 883
Genetic studies in intellectual disability and related disorders
Vissers, L. E. L. M., Gilissen, C., & Veltman, J. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg3999 · Cited by 761
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Axonal transport: cargo-specific mechanisms of motility and regulation
Maday, S., Twelvetrees, A. E., Moughamian, A. J., & Holzbaur, E. L. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.019 · Cited by 683
Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2
Schmeisser, M. J., Ey, E., Wegener, S., Bockmann, J., Stempel, A. V., Kuebler, A., Janssen, A.-L., Udvardi, P. T., Shiban, E., Spilker, C., et al. (2012) · Nature · doi:10.1038/nature11015 · Cited by 638
Modeling Autism by SHANK Gene Mutations in Mice
Jiang, Y.-H., & Ehlers, M. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.016 · Cited by 488
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470
Dendritic structural plasticity and neuropsychiatric disease
Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464
Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002521 · Cited by 429
De Novo Mutations in Moderate or Severe Intellectual Disability
Hamdan, F. F., Srour, M., Capo-Chichi, J.-M., Daoud, H., Nassif, C., Patry, L., Massicotte, C., Ambalavanan, A., Spiegelman, D., Diallo, O., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004772 · Cited by 419
Clement, J. P., Aceti, M., Creson, T. K., Ozkan, E. D., Shi, Y., Reish, N. J., Almonte, A. G., Miller, B. H., Wiltgen, B. J., Miller, C. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.045 · Cited by 385
Genetic and Epigenetic Networks in Intellectual Disabilities
van Bokhoven, H. (2011) · Annual Review of Genetics · doi:10.1146/annurev-genet-110410-132512 · Cited by 382
Soorya, L. V., Kolevzon, A. L., Zweifach, J., Lim, T., Dobry, Y., Schwartz, L., Frank, Y., Wang, A. T., Cai, G., Parkhomenko, E., et al. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-18 · Cited by 345
Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
SHANK1 Deletions in Males with Autism Spectrum Disorder
Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I. E., Hamdan, F. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.017 · Cited by 318
Self-citationGRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine
Pierson, T. M., Yuan, H., Marsh, E. D., Fajardo, K. V. F., Adams, D. R., Markello, T. C., Golas, G. A., Simeonov, D. R., Holloman, C., Tankovic, A., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.39 · Cited by 294
Berryer, M. H., Hamdan, F. F., Klitten, L. L., Møller, R. S., Carmant, L., Schwartzentruber, J., Patry, L., Dobrzeniecka, S., Rochefort, D., Neugnot-Cerioli, M., et al. (2013) · Human Mutation · doi:10.1002/humu.22248 · Cited by 266
Redin, C. E., Gérard, B., Lauer, J., Herenger, Y., Muller, J., Quartier, A., Masurel, A., Willems, M., Lesca, G., Chehadeh, S. E., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102554 · Cited by 274
Synaptopathies: diseases of the synaptome
Grant, S. G. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.002 · Cited by 248
Platzer, K., Yuan, H., Schutz, H. M., Winschel, A., Chen, W., Hu, C., Kusumoto, H., Heyne, H., Helbig, K. L., Tang, S., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104509 · Cited by 262
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Salpietro, V., Dixon, C. L., Guo, H., Bello, O. D., Vandrovcová, J., Efthymiou, S., Maroofian, R., Heimer, G., Bürglen, L., Valence, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10910-w · Cited by 252
Intellectual disability and autism spectrum disorders: Causal genes and molecular mechanisms
Srivastava, A. K., & Schwartz, C. E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.015 · Cited by 273
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
Boccuto, L., Lauri, M., Sarasua, S. M., Skinner, C. D., Buccella, D., Dwivedi, A., Orteschi, D., Collins, J. S., Zollino, M., Visconti, P., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.175 · Cited by 240
Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies
Grabrucker, A. M., Schmeisser, M. J., Schoen, M., & Boeckers, T. M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.07.003 · Cited by 233
Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F. F., Xiong, L., Piton, A., Spiegelman, D., Henrion, É., Millet, B., S2D team, et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.52 · Cited by 231
SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy
Vlaskamp, D. R. M., Shaw, B. J., Burgess, R., Mei, D., Montomoli, M., Xie, H., Myers, C. T., Bennett, M. F., XiangWei, W., Williams, D., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006729 · Cited by 206
Bonaglia, M. C., Giorda, R., Beri, S., De Agostini, C., Novara, F., Fichera, M., Grillo, L., Galesi, O., Vetro, A., Ciccone, R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002173 · Cited by 224
Gandal, M. J., Sisti, J., Klook, K., Ortinski, P. I., Leitman, V, Liang, Y., Thieu, T., Anderson, R., Pierce, R. C., Jonak, G., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.69 · Cited by 204
Rivière, J., Ramalingam, S., Lavastre, V., Shekarabi, M., Holbert, S., Lafontaine, J., Srour, M., Merner, N. D., Rochefort, D. L., Hince, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.013 · Cited by 209
Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy
Lemke, J. R., Geider, K., Helbig, K. L., Heyne, H. O., Schütz, H., Hentschel, J., Courage, C., Depienne, C., Nava, C., Heron, D., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002740 · Cited by 200
Rubeis, S. D., Siper, P. M., Durkin, A., Weissman, J., Muratet, F., Halpern, D. B., Trelles, M. P., Frank, Y., Lozano, R., Wang, A. T., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0205-9 · Cited by 202
NMDA receptor subunit mutations in neurodevelopmental disorders
Burnashev, N., & Szepetowski, P. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.008 · Cited by 201
Yavarna, T., Al-Dewik, N. I. E., Al‐Mureikhi, M., Ali, R., Al‐Mesaifri, F., Mahmoud, L., Shahbeck, N., Lakhani, S., AlMulla, M., Nawaz, Z., et al. (2015) · Human Genetics · doi:10.1007/s00439-015-1575-0 · Cited by 202
Betancur, C., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-17 · Cited by 189
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
Küry, S., van Woerden, G. M., Besnard, T., Proietti Onori, M., Latypova, X., Towne, M. C., Cho, M. T., Prescott, T. E., Ploeg, M. A., Sanders, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.10.003 · Cited by 185
Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy
Mignot, C., von Stülpnagel, C., Nava, C., Ville, D. M., Sanlaville, D., Lesca, G., Rastetter, A., Gachet, B., Marie, Y., Korenke, G. C., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103451 · Cited by 189
Swanger, S. A., Chen, W., Wells, G., Burger, P. B., Tankovic, A., Bhattacharya, S., Strong, K. L., Hu, C., Kusumoto, H., Zhang, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.10.002 · Cited by 183
Klebe, S., Stévanin, G., & Depienne, C. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.02.017 · Cited by 179
Bozdagi, O., Tavassoli, T., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-9 · Cited by 176
Iqbal, Z., Vandeweyer, G., van der Voet, M., Waryah, A., Zahoor, M., Besseling, J., Roca, L. T., Silfhout, A. T. V.-V., Nijhof, B., Kramer, J. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt043 · Cited by 175
Wang, X., Xu, Q., Bey, A. L., Lee, Y., & Jiang, Y. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-30 · Cited by 173
Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat
Harony-Nicolas, H., Kay, M., Hoffmann, J. D., Klein, M. E., Bozdagi-Gunal, O., Riad, M., Daskalakis, N. P., Sonar, S., Castillo, P. E., Hof, P. R., et al. (2017) · eLife · doi:10.7554/elife.18904 · Cited by 168
Mechanisms of disease in hereditary sensory and autonomic neuropathies
Rotthier, A., Baets, J., Timmerman, V., & Janssens, K. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.227 · Cited by 166
Lee, J.-R., Srour, M., Kim, D., Hamdan, F. F., Lim, S.-H., Brunel‐Guitton, C., Décarie, J., Rossignol, E., Mitchell, G. A., Schreiber, A., et al. (2014) · Human Mutation · doi:10.1002/humu.22709 · Cited by 160
Kolevzon, A., Angarita, B., Bush, L., Wang, A. T., Frank, Y., Yang, A., Rapaport, R., Saland, J. M., Srivastava, S., Farrell, C., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-39 · Cited by 166
Novel genetic causes for cerebral visual impairment
Bosch, D. G. M., Boonstra, F. N., de Leeuw, N., Pfundt, R., Nillesen, W. M., de Ligt, J., Gilissen, C., Jhangiani, S. N., Lupski, J. R., Cremers, F. P. M., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.186 · Cited by 155
Jaramillo, T. C., Speed, H. E., Xuan, Z., Reimers, J. M., Liu, S., & Powell, C. M. (2015) · Autism Research · doi:10.1002/aur.1529 · Cited by 160
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
Phenotypic expansion illuminates multilocus pathogenic variation
Karaca, E., Posey, J. E., Coban‐Akdemir, Z., Pehli̇van, D., Harel, T., Jhangiani, S. N., Bayram, Y., Song, X., Bahrambeigi, V., Yüreğir, Ö. Ö., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.33 · Cited by 147
Lee, J., Chung, C., Ha, S., Lee, D., Kim, D. Y., Kim, H., & Kim, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00094 · Cited by 153
Wei, F., Yan, L.-M., Su, T., He, N., Lin, Z.-J., Wang, J., Shi, Y., Yi, Y., & Liao, W. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0134-1 · Cited by 147
Ozkan, E. D., Creson, T. K., Kramár, E. A., Rojas, C., Seese, R. R., Babyan, A. H., Shi, Y., Lucero, R., Xu, X., Noebels, J. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.015 · Cited by 144
The Protein 4.1 family: Hub proteins in animals for organizing membrane proteins
Baines, A. J., Lu, H., & Bennett, P. M. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.05.030 · Cited by 143
Aceti, M., Creson, T. K., Vaissiere, T., Rojas, C., Huang, W.-C., Wang, Y.-X., Petralia, R. S., Page, D. T., Miller, C. A., & Rumbaugh, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.001 · Cited by 129
Tesson, C., Koht, J. A., & Stévanin, G. (2015) · Human Genetics · doi:10.1007/s00439-015-1536-7 · Cited by 150
Yuan, H., Hansen, K. B., Zhang, J., Pierson, T. M., Markello, T. C., Fajardo, K. V. F., Holloman, C., Golas, G. A., Adams, D. R., Boerkoel, C. F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4251 · Cited by 143
Glutamatergic synapses in neurodevelopmental disorders
Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.014 · Cited by 146
AMPA receptor structure and auxiliary subunits
Kamalova, A., & Nakagawa, T. (2020) · The Journal of Physiology · doi:10.1113/jp278701 · Cited by 139
De novo mutations and rare variants occurring in NMDA receptors
XiangWei, W., Jiang, Y., & Yuan, H. (2017) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.12.013 · Cited by 133
Merner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 129
De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy
Nieh, S. E., Madou, M. R. Z., Sirajuddin, M., Fregeau, B., McKnight, D., Lexa, K. W., Strober, J. B., Spaeth, C. G., Hallinan, B. E., Smaoui, N., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.198 · Cited by 119
Phelan–McDermid Syndrome and SHANK3: Implications for Treatment
Costales, J. L., & Kolevzon, A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0352-z · Cited by 130
Nelson, A. D., & Jenkins, P. M. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00136 · Cited by 132
Update on the Genetics of Spastic Paraplegias
Boutry, M., Morais, S., & Stévanin, G. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0930-2 · Cited by 118
Jeyabalan, N., & Clement, J. P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00032 · Cited by 130
van de Warrenburg, B. P. C., Schouten, M. I., de Bot, S. T., Vermeer, S., Meijer, R. P. P., Pennings, M., Gilissen, C., Willemsen, M. A., Scheffer, H., & Kamsteeg, E. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.42 · Cited by 115
Parker, M. J., Fryer, A. E., Shears, D. J., Lachlan, K. L., McKee, S. A., Magee, A. C., Mohammed, S. N., Vasudevan, P. C., Park, S., Benoît, V., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37189 · Cited by 116
Ting, J. T., Peça, J., & Feng, G. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150442 · Cited by 110
Genetic Basis of Intellectual Disability
Ellison, J. W., Rosenfeld, J. A., & Shaffer, L. G. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140053 · Cited by 110
Alvarado, S. G., Tajerian, M., Millecamps, M., Suderman, M. J., Stone, L. S., & Szyf, M. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-21 · Cited by 105
Willemsen, M. H., Ba, W., Wissink-Lindhout, W. M., de Brouwer, A. P. M., Haas, S. A., Bienek, M., Hu, H., Vissers, L. E. L. M., van Bokhoven, H., Kalscheuer, V. M., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102182 · Cited by 99
De novo mutations in GRIN1 cause extensive bilateral polymicrogyria
Fry, A. E., Fawcett, K. A., Zelnik, N., Yuan, H., Thompson, B. A. N., Shemer-Meiri, L., Cushion, T. D., Mugalaasi, H., Sims, D., Stoodley, N., et al. (2017) · Brain · doi:10.1093/brain/awx358 · Cited by 105
Intellectual disability genomics: current state, pitfalls and future challenges
Maia, N., Sá, M. J. N., Pires, M. M., de Brouwer, A. P. M., & Jorge, P. (2021) · BMC Genomics · doi:10.1186/s12864-021-08227-4 · Cited by 116
Ku, C., Polychronakos, C., Tan, E., Naidoo, N., Yudi Pawitan, Y., Roukos, D. H., Mort, M. E., & Cooper, D. N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.58 · Cited by 99
Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners
Levy, A. M., Gómez‐Puertas, P., & Tümer, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084390 · Cited by 100
Chilian, B., Abdollahpour, H., Bierhals, T., Haltrich, I., Fekete, G., Nagel, I., Rosenberger, G., & Kutsche, K. (2013) · Clinical Genetics · doi:10.1111/cge.12105 · Cited by 85
Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice
Nakajima, R., Takao, K., Hattori, S., Shoji, H., Komiyama, N. H., Grant, S. G. N., & Miyakawa, T. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12073 · Cited by 92
Berryer, M. H., Chattopadhyaya, B., Xing, P., Riebe, I., Bosoi, C., Sanon, N., Antoine-Bertrand, J., Lévesque, M., Avoli, M., Hamdan, F. F., et al. (2016) · Nature Communications · doi:10.1038/ncomms13340 · Cited by 93
Self-citationNeed, A. C., McEvoy, J. P., Gennarelli, M., Heinzen, E. L., Ge, D., Maia, J. M., Shianna, K. V., He, M., Cirulli, E. T., Gumbs, C. E., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.018 · Cited by 92
Ohba, C., Shiina, M., Tohyama, J., Haginoya, K., Lerman‐Sagie, T., Okamoto, N., Blumkin, L., Lev, D., Mukaida, S., Nozaki, F., et al. (2015) · Epilepsia · doi:10.1111/epi.12987 · Cited by 92
Mechanical coupling maintains the fidelity of NMDA receptor–mediated currents
Kazi, R., Dai, J., Sweeney, C., Zhou, H., & Wollmuth, L. P. (2014) · Nature Neuroscience · doi:10.1038/nn.3724 · Cited by 92
Scaffold Proteins at the Postsynaptic Density
Verpelli, C., Schmeisser, M. J., Sala, C., & Boeckers, T. M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_2 · Cited by 92
Kozol, R. A., Cukier, H. N., Zou, B., Mayo, V., Rubeis, S. D., Cai, G., Griswold, A. J., Whitehead, P. L., Haines, J. L., Gilbert, J. R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv138 · Cited by 95
Cochoy, D. M., Kolevzon, A. L., Kajiwara, Y., Schoen, M., Pascual‐Lucas, M., Lurie, S., Buxbaum, J. D., Boeckers, T. M., & Schmeißer, M. J. (2015) · Molecular Autism · doi:10.1186/s13229-015-0020-5 · Cited by 89
Exome sequencing and the genetics of intellectual disability
Topper, S., Ober, C., & Das, S. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01720.x · Cited by 91
GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function
Chen, W., Shieh, C., Swanger, S. A., Tankovic, A., Au, M., McGuire, M., Tagliati, M., Graham, J. M., Madan‐Khetarpal, S., Traynelis, S. F., et al. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.19 · Cited by 86
Boyle, L., Rao, L., Kaur, S., Fan, X., Mebane, C. M., Hamm, L., Thornton, A., Ahrendsen, J. T., Anderson, M. P., Christodoulou, J., et al. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100026 · Cited by 84
Recurrent gene flow between Neanderthals and modern humans over the past 200,000 years
Li, L., Comi, T. J., Bierman, R., & Akey, J. M. (2024) · Science · doi:10.1126/science.adi1768 · Cited by 94
Davarnia, B., Hu, H., Kahrizi, K., Musante, L., Fattahi, Z., Hosseini, M., Maqsoud, F., Farajollahi, R., Wienker, T. F., Ropers, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129631 · Cited by 83
Kobayashi, Y., Tohyama, J., Kato, M., Akasaka, N., Magara, S., Kawashima, H., Ohashi, T., Shiraishi, H., Nakashima, M., Saitsu, H., et al. (2016) · Brain and Development · doi:10.1016/j.braindev.2015.09.011 · Cited by 84
Soto, D., Olivella, M., Grau, C., Armstrong, J., Alcon, C., Gasull, X., Santos‐Gómez, A., Locubiche, S., de Salazar, M. G., García-Díaz, R., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aaw0936 · Cited by 86
Harony‐Nicolas, H., Rubeis, S. D., Kolevzon, A. L., & Buxbaum, J. D. (2015) · Journal of Child Neurology · doi:10.1177/0883073815600872 · Cited by 83
Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice
Amador, A., Bostick, C. D., Olson, H. E., Peters, J., Camp, C. R., Krizay, D. K., Chen, W., Han, W., Tang, W., Kanber, A., et al. (2020) · Brain · doi:10.1093/brain/awaa147 · Cited by 79
Holder, J. L., & Quach, M. M. (2016) · Epilepsia · doi:10.1111/epi.13506 · Cited by 78
Glutamate receptor mutations in psychiatric and neurodevelopmental disorders
Soto, D., Altafaj, X., Sindreu, C. B., & Bayés, À. (2014) · Communicative & Integrative Biology · doi:10.4161/cib.27887 · Cited by 76
Neurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeißer, M. J., Krueger‐Burg, D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 80
Metadata
- Authors
- Hamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., Tomitori, H., Daoud, H., Massicotte, C., Henrion, E., Diallo, O., Shekarabi, M., Marineau, C., Shevell, M., Maranda, B., Mitchell, G., Nadeau, A., D'Anjou, G., Vanasse, M., Srour, M., Lafrenière, R. G., Drapeau, P., Lacaille, J. C., Kim, E., Lee, J.-R., Igarashi, K., Huganir, R. L., Rouleau, G. A., & Michaud, J. L.
- Affiliations
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Howard Hughes Medical Institute (US)
- Chiba University (JP)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Montreal Children's Hospital (CA)
- Centre hospitalier de l'Université Laval (CA)
- Université de Montréal (CA)
- Korea Advanced Institute of Science and Technology (KR)
- Corresponding author
- Michaud, Jacques L.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 88
- Issue
- 3
- Pages
- 306-316
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC3059427
- OpenAlex
- W2033759150
- Cited by
- 349
- References
- 58
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 15 · 2023: 19 · 2022: 16 · 2021: 20 · 2020: 24 · 2019: 24 · 2018: 21 · 2017: 37 · 2016: 18 · 2015: 38 · 2014: 30 · 2013: 19 · 2012: 31
- FWCI
- 18.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Japan Society for the Promotion of Science (23390038)
- National Institute of Neurological Disorders and Stroke (R01NS036715)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- non-syndromic intellectual disability, de novo mutations, glutamate receptors, glutamatergic synapses, synaptic genes, missense mutations, truncating mutations, splicing mutation, SYNGAP1, STXBP1, SHANK3, KIF1A, GRIN1, protein function
- MeSH terms
- Animals, Base Sequence, Cytoskeletal Proteins, Female, Humans, Male, Membrane Proteins, Intellectual Disability, Mutation, Neuropeptides, Phenotype, Protein Binding, RNA Splicing, Subcellular Fractions, Syndrome, Calcium Channels, Receptors, N-Methyl-D-Aspartate, Kinesins, Receptors, AMPA, Glutamic Acid, Amino Acid Substitution, Mutation, Missense, Protein Transport, Rats, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review